Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD

Background: Prospective pharmacological studies on breathomics profiles in COPD patients have not been previously reported. We assessed the effects of treatment and withdrawal of an extrafine inhaled corticosteroid (ICS)-long-acting β(2)-agonist (LABA) fixed dose combination (FDC) using a multidimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Montuschi, Paolo, Santini, Giuseppe, Mores, Nadia, Vignoli, Alessia, Macagno, Francesco, Shoreh, Rugia, Tenori, Leonardo, Zini, Gina, Fuso, Leonello, Mondino, Chiara, Di Natale, Corrado, D'Amico, Arnaldo, Luchinat, Claudio, Barnes, Peter J., Higenbottam, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914154/
https://www.ncbi.nlm.nih.gov/pubmed/29719507
http://dx.doi.org/10.3389/fphar.2018.00258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914154/
https://www.ncbi.nlm.nih.gov/pubmed/29719507
http://dx.doi.org/10.3389/fphar.2018.00258

Ejemplares similares